Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of amfepramone 75 mg capsules under fasting and fed conditions
ACTRN12619000391178Phase 3Completed
- Sponsor
- Investigación Farmacéutica
- Start
- Feb 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of amfepramone in obesity (4 arms), sponsored by Investigación Farmacéutica. Primary endpoints: AUC0-t, AUC0-inf and 1 more. Started Feb 2017; status: completed.
02
Drugs
amfepramone
03
Conditions
obesity
Beyond the preview
Go deeper on ACTRN12619000391178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000391178.